… NCT01024413) comparing erlotinib with gefitinib for patients with exon 21 mutations. The …
trial by the appropriate independent ethics committees at the Guangdong Lung Cancer Institute…

… next clinical trial. A phase 1/2 clinical trial that investigated the combination of erlotinib and
… A phase 3 clinical trial compared erlotinib alone with erlotinib plus bevacizumab in patients …

… Epidermal growth factor receptor (EGFR) –tyrosine kinase inhibitors have proven efficacy
in advanced non–small-cell lung cancer (NSCLC). We hypothesized that erlotinib would be …

… Symptom improvement in lung cancer patients treated with erlotinib: quality of life
analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. …

… phase 2 trial of erlotinib among previously treated patients with non–small-cell lung cancer
in … For this reason, the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) …

… Phase III trials with erlotinib in non-small cell lung cancer and pancreatic cancer are in
progress, as are a range of studies in various indications designed to optimize the use of erlotinib …

… shown preliminary activity in non–small-cell lung cancer (NSCLC). Patients with advanced
NSCLC were treated with erlotinib with or without sorafenib in this multicenter phase II trial. …

… trial that compared erlotinib with a placebo for non–small-cell lung cancer demonstrated a
survival benefit for erlotinib… in this trial to investigate whether responsiveness to erlotinib and …

… Thus, we did the TArceva Italian Lung Optimization tRial (TAILOR), to compare erlotinib
with docetaxel in patients who failed first-line platinum-based chemotherapy and who had the …

… in four randomized phase III trials. In these studies, concurrent administration of erlotinib or
gefitinib with … of docetaxel or pemetrexed followed by erlotinib resulting in promising activity. …